Research
Energy balance
GLP-1 receptor agonist type drugs can help patients achieve considerable weight loss.
Practitioners can consider GLP-1 RAs as a treatment option for weight loss in obese patients.
StrongSupportsmedium confidence
Glucagon-like peptide-1 receptor agonist (GLP-1 RA) type drugs have the potential to help patients achieve considerable weight loss.
Why this rating
The claim is based on the potential benefits of GLP-1 RAs as stated in the abstract.
Source
Navigating the benefits and harms of GLP-1 and GLP-1/GIP agonists in obesity
Raymond J. O’Connor · Drug and Therapeutics Bulletin · 2026
reviewCited 1×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →